Early Myoclonic Encephalopathy and Nonketotic Hyperglycinemia

作者: Samantha Rossi , Irene Daniele , Petrina Bastrenta , Massimo Mastrangelo , Gianluca Lista

DOI: 10.1016/J.PEDIATRNEUROL.2009.05.005

关键词:

摘要: Early myoclonic encephalopathy is an epileptic syndrome with different etiologies. Nonketotic hyperglycinemia one cause. We describe two cases of early encephalopathy, secondary to nonketotic hyperglycinemia, fatal evolution in the neonatal period. These may better clarify clinical findings that can be associated impairment glycine metabolism. Distinguishing features include agenesis corpus callosum patient 1, and weight loss exceeding 10%, metabolic acidosis, 2. The burst-suppression electroencephalography pattern relatively common encephalopathies, frequently seizures. inborn error metabolism caused by mutations genes encoding protein mitochondrial cleavage system. form a severe, lethal neurologic disease. When electro-clinical features, progressive lethargy hypotonia occur first days life, progressing apnea often death. Prospective treatment oral sodium benzoate, N-methyl-d-aspartate receptor antagonist ketamine, dextromethorphan favorably modify early neonatal course severe but does not prevent poor long-term outcomes.

参考文章(12)
Joseph J. Volpe, Neurology of the Newborn ,(1981)
A. Dinopoulos, S. Kure, G. Chuck, K. Sato, D. L. Gilbert, Y. Matsubara, T. Degrauw, Glycine decarboxylase mutations: A distinctive phenotype of nonketotic hyperglycinemia in adults Neurology. ,vol. 64, pp. 1255- 1257 ,(2005) , 10.1212/01.WNL.0000156800.23776.40
J. L. K. Van Hove, K. Vande Kerckhove, J. B. Hennermann, V. Mahieu, P. Declercq, S. Mertens, M. De Becker, P. S. Kishnani, J. Jaeken, Benzoate treatment and the glycine index in nonketotic hyperglycinaemia. Journal of Inherited Metabolic Disease. ,vol. 28, pp. 651- 663 ,(2005) , 10.1007/S10545-005-0033-X
Ada Hamosh, John W. McDonald, David Valle, Clair A. Francomano, Ernst Niedermeyer, Michael V. Johnston, Dextromethorphan and high-dose benzoate therapy for nonketotic hyperglycinemia in an infant The Journal of Pediatrics. ,vol. 121, pp. 131- 135 ,(1992) , 10.1016/S0022-3476(05)82559-4
Massimo Mastrangelo, Laura Canafoglia, Silvana Franceschetti, Chiara Oppezzo, Fabio Mosca, Francesca Menni, Rossella Parini, Claudia Ciano, Vidmer Scaioli, Ferruccio Panzica, High-frequency rhythmic cortical myoclonus in a long-surviving patient with nonketotic hypergylcemia Journal of Child Neurology. ,vol. 23, pp. 321- 324 ,(2008) , 10.1177/0883073807308699
Yin-Hsiu Chien, Chia-Chi Hsu, Aichu Huang, Shi-Ping Chou, Frank-Li Lu, Wang-Tso Lee, Wuh-Liang Hwu, Poor outcome for neonatal-type nonketotic hyperglycinemia treated with high-dose sodium benzoate and dextromethorphan. Journal of Child Neurology. ,vol. 19, pp. 39- 42 ,(2004) , 10.1177/08830738040190010702
E. Zammarchi, Maria Donati, Federica Ciani, Elisabetta Pasquini, Ivana Pela, P. Fiorini, Failure of early dextromethorphan and sodium benzoate therapy in an infant with nonketotic hyperglycinemia Neuropediatrics. ,vol. 25, pp. 274- 276 ,(1994) , 10.1055/S-2008-1073037
Shunsuke Ohtahara, Yasuko Yamatogi, Epileptic encephalopathies in early infancy with suppression-burst. Journal of Clinical Neurophysiology. ,vol. 20, pp. 398- 407 ,(2003) , 10.1097/00004691-200311000-00003
Stanley H. Korman, Isaiah D. Wexler, Alisa Gutman, Marie‐Odile Rolland, Junko Kanno, Shigeo Kure, Treatment from birth of nonketotic hyperglycinemia due to a novel GLDC mutation Annals of Neurology. ,vol. 59, pp. 411- 415 ,(2006) , 10.1002/ANA.20759